(Q40564045)

English

NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors

scientific article published on April 2004

Statements

NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors (English)
Eugene Maraskovsky
Sigrid Sjölander
Anders Sjölander
Martin J Pearse
Francois A Lemonnier
Jonathan Cebon

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit